Kunrong Cheng

Deoxycholic acid conjugates are muscarinic cholinergic receptor antagonists.

Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.

Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line.

Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry.

Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.

Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells.

3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.

Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.

Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.

Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.

Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.

Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.

Muscarinic receptors and ligands in cancer.

Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.

Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.

Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury.

In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice.

Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.

Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice.

Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.

Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice.

Bedside to bench: role of muscarinic receptor activation in ultrarapid growth of colorectal cancer in a patient with pheochromocytoma.

Phrygian Cap Appearance of a Mouse Gallbladder on Magnetic Resonance Imaging.

Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.

In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport.

Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging.

M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury.

Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids.

M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.